Related Experiment Videos

[Fatal cerebral aspergillosis in acute megakaryoblastic leukemia]

C Perrin1, P Boutard, O Reman

  • 1Service de Réanimation médicale (Unité Pédiatrique), CHRU, Caen.

Archives Francaises De Pediatrie
|January 1, 1989
PubMed

Insights

A child with acute megakaryoblastic leukemia developed invasive pulmonary aspergillosis during chemotherapy. Despite antifungal treatment, disseminated aspergillosis led to a fatal outcome, highlighting the need for early diagnosis and intervention in immunocompromised patients.

Area of Science:

  • Hematology
  • Mycology
  • Infectious Diseases

Background:

  • Acute megakaryoblastic leukemia is a rare and aggressive hematologic malignancy.
  • Immunosuppression during chemotherapy increases the risk of opportunistic infections, such as invasive fungal infections.
  • Aspergillosis, a serious fungal infection caused by Aspergillus species, poses a significant threat to immunocompromised individuals.

Observation:

  • A 13-year-old girl with acute megakaryoblastic leukemia developed a severe infectious syndrome during chemotherapy.
  • Initial broad-spectrum antibiotic therapy was ineffective.
  • Pulmonary aspergillosis was diagnosed via bronchoalveolar lavage.
  • The patient received Itraconazole, a triazole antifungal agent.

Findings:

  • Despite Itraconazole treatment, the patient's condition rapidly deteriorated.
  • Death occurred three days after initiating antifungal therapy.
  • Autopsy revealed widespread Aspergillus abscesses in the brain and other organs, confirming disseminated aspergillosis.
  • Cerebral aspergillosis led to coma and transtentorial herniation.

Implications:

  • Early and accurate diagnosis of invasive aspergillosis in immunocompromised patients is critical.
  • Prompt initiation of effective antifungal therapy is essential for improving patient outcomes.
  • This case underscores the challenges in managing invasive fungal infections in patients with hematologic malignancies.

Related Concept Videos